Top compounds associated with response to PRNT


Feature Type Standardized
Nominal ANOVA
mRNA LY-2157299 CTRPv2 pan-cancer AAC -0.058 0.4
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC -0.056 0.4
mRNA tigecycline CTRPv2 pan-cancer AAC -0.037 0.4
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.038 0.4
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.031 0.4
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.028 0.4
mRNA NSC632839 CTRPv2 pan-cancer AAC -0.025 0.4
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.023 0.4
Download CSV